NCT06023251 Improving Nutritional Adequacy of ICU Survivors in a Prospective Interventional Way: the Bright Side Study
| NCT ID | NCT06023251 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Universitair Ziekenhuis Brussel |
| Condition | Malnutrition |
| Study Type | INTERVENTIONAL |
| Enrollment | 100 participants |
| Start Date | 2023-10-04 |
| Primary Completion | 2026-08-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 100 participants in total. It began in 2023-10-04 with a primary completion date of 2026-08-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The objective is to increase caloric adequacy in patients who survived critical illness and are admitted to the ward by the use of a pro-active inclusive nutritional strategy including supplemental parenteral and/or enteral nutrition and/or oral nutritional supplements guided by indirect calorimetry. This enables the investigators to address, within a clinical/scientific context, a recently demonstrated but until now relatively neglected 'dark side' of patient care at UZ Brussel, comparable to limited global evidence : iatrogenic malnutrition of ICU survivors. The use of a newly developed clinical pathway and nutrition strategy (oral, enteral and parenteral) led by a single SPoC (Single Point of Contact) for patients surviving intensive care will have a clear objective: to address the nutritional deficit in all patients.
Eligibility Criteria
Inclusion Criteria: * Adult ≥ 18 years * ICU stay ≥ 7 days * Ward stay ≥ 3 days * Nutritional therapy not restricted * Heterogeneous diseases Exclusion Criteria: * Patients \< 18 years * ICU \< 7 days * Ward stay \< 3 days * Advanced Care Planning with impact on nutritional therapy * Patients with palliative care * Metabolic derangements such as metabolic diseases * Pregnancy
Contact & Investigator
Elisabeth De Waele, MD PhD
PRINCIPAL INVESTIGATOR
Universitair Ziekenhuis Brussel, Vrije universiteit Brussel
Frequently Asked Questions
Who can join the NCT06023251 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Malnutrition. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06023251 currently recruiting?
Yes, NCT06023251 is actively recruiting participants. Contact the research team at zenzi.rosseel@uzbrussel.be for enrollment information.
Where is the NCT06023251 trial being conducted?
This trial is being conducted at Brussels, Belgium.
Who is sponsoring the NCT06023251 clinical trial?
NCT06023251 is sponsored by Universitair Ziekenhuis Brussel. The principal investigator is Elisabeth De Waele, MD PhD at Universitair Ziekenhuis Brussel, Vrije universiteit Brussel. The trial plans to enroll 100 participants.